Search research articles
Contact Us
Filters
Showing results (601-610 of 619) with videos related to
Page
of 62
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2015
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108
Paul M Barr, Hongli Li, Catherine Spier, et al.
Blood
|
July 24, 2019
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
Deborah M Stephens, Hongli Li, Heiko Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer
Evan Y Yu, Hongli Li, Celestia S Higano, et al.
Cell Reports. Medicine
|
April 8, 2026
Preclinical evaluation of an mRNA vaccine developed from the first human isolate of bovine H5N1
Hongli Li, Mengting Huang, Simin Feng, et al.
Frontiers in Pediatrics
|
November 11, 2024
Impact of the COVID-19 pandemic on epidemiological and clinical characteristics of <i>Mycoplasma pneumoniae</i> pneumonia in children: a multicenter study from Hubei, China
Hui Du, Jun Li, Xilin Li, et al.
International Journal of Cancer
|
September 16, 2014
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial
Amir Goldkorn, Benjamin Ely, Catherine M Tangen, et al.
Blood Advances
|
September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Colleen A Ramsower, George Wright, Hongli Li, et al.
British Journal of Haematology
|
December 20, 2016
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106
Robert W Chen, Hongli Li, Steven H Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2020
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001
Daniel O Persky, Hongli Li, Deborah M Stephens, et al.
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
Page
of 62
Search research articles
Search
Showing results (601-610 of 619) with videos related to
Sort By:
Page
of 62
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2015
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108
Paul M Barr, Hongli Li, Catherine Spier, et al.
Blood
|
July 24, 2019
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
Deborah M Stephens, Hongli Li, Heiko Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer
Evan Y Yu, Hongli Li, Celestia S Higano, et al.
Cell Reports. Medicine
|
April 8, 2026
Preclinical evaluation of an mRNA vaccine developed from the first human isolate of bovine H5N1
Hongli Li, Mengting Huang, Simin Feng, et al.
Frontiers in Pediatrics
|
November 11, 2024
Impact of the COVID-19 pandemic on epidemiological and clinical characteristics of <i>Mycoplasma pneumoniae</i> pneumonia in children: a multicenter study from Hubei, China
Hui Du, Jun Li, Xilin Li, et al.
International Journal of Cancer
|
September 16, 2014
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial
Amir Goldkorn, Benjamin Ely, Catherine M Tangen, et al.
Blood Advances
|
September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Colleen A Ramsower, George Wright, Hongli Li, et al.
British Journal of Haematology
|
December 20, 2016
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106
Robert W Chen, Hongli Li, Steven H Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2020
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001
Daniel O Persky, Hongli Li, Deborah M Stephens, et al.
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
Page
of 62